article thumbnail

Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test

XTalks

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.

article thumbnail

IN FOCUS: Syngene International

Pharmaceutical Technology

The company undertook several initiatives recently to expand its business through new partnerships, expansion of existing relationships, and investment in manufacturing capacity. Initially centered on Librela®, this agreement paves the way for developing and manufacturing other molecules in the coming years. until 2026.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fortis Life Sciences leads the way in custom antibody discovery

Drug Discovery World

Fortis Life Sciences offers custom antibody discovery and manufacturing services for antibodies and single-domain antibodies, supporting the drug discovery market. Moreover, custom antibodies are a key reagent in companion diagnostics for these novel therapeutics.

article thumbnail

Blood Donor Day 2023: Experts weigh in 

Drug Discovery World

One example we are following with anticipation are the two FDA approvals for the first gene therapies for sickle cell disease. We offer a Cell Collections training program geared to biotechs, teaching how to shorten, streamline and standardise the collection process which can help reduce costs, and scale cell manufacturing.